Follitech AB

Follitech was founded in 2010 and has a strong collaboration with a group of scientists at the Department of Medical Chemistry and Biophysics at Umeå University. The company aims to address and treat infertility associated with POF (premature ovarian failure). POF is a condition that affects 1 in 100 women, and in these women the ovaries prematurely stop their monthly production of mature eggs before they reach 40 years of age. The condition is also associated with a reduction of estrogen which causes classical symptoms and health problems associated with menopause in these young women, but in particular, infertility due to the lack of mature eggs. At the moment, there are no treatment for POF, but the company have make discoveries and see potential in finding a treatment in the years to come.


Contact: Liu Kui

Contact details
BOX 7995, SE-90719 Umeå, Sweden
Phone: +4690 - 786 77 62